Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm IncfiledCriticalOrtho Mcneil Pharm Inc
Priority to CR8322ApriorityCriticalpatent/CR8322A/en
Publication of CR8322ApublicationCriticalpatent/CR8322A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Esta invencion provee arilindenopiridinas y arilindenopirimidinas novedosas de la formula (I), (II).This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula (I), (II).
CR8322A2006-04-032006-04-03
ARYLINDENOPIRIDINS AND ARYLINDENOPIRIMIDINS AND THEIR USE AS ANTAGONIST OF THE ADENOSINE A2A RECEIVER
CR8322A
(en)
2-AMINO-9- [4- (4-METOXI-PHENOXI) -PIPERIDIN-1-IL] -4-PHENYL-INDENO [1,2-D] PYRIMIDIN-5-ONA AND ITS USE AS AN RECEIVER ANTAGONIST ADENOSINA A2A HIGHLY SELECTIVE